Study of Autologous Neo-Bladder Construct in Subjects With Neurogenic Bladder Following Spinal Cord Injury

Stopped early · Phase 2

Conditions studied: Neurogenic Bladder

In brief

Subjects with neurogenic bladder secondary to spinal cord injury that is refractory to medical treatment and requires augmentation cystoplasty will be enrolled. The hypothesis is that augmentation cystoplasty using an autologous neo-bladder construct will reduce maximum detrusor pressure.

Key facts

Study ID

NCT00512148

Run by

Tengion

People needed

7

Starts

2007-07-01

Expected to finish

2011-04-01

Last updated by the study team

2018-08-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• subjects with neurogenic bladders secondary to spinal cord injury

You may not qualify if…

• prior augmentation procedures or urinary diversion
• recent urologic or intraperitoneal surgery or device implantation
• recent history of spinal cord injury of less than a year
• recent neurologic surgery
• requirement for concomitant urological surgical procedures

Where it is running

• Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.